Company Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Numinus Wellness Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Delayed Toronto S.E. Other stock markets 09:45:35 2024-04-29 EDT			5-day change	1st Jan Change
0.08 ^CAD	+6.67%		0.00%	-27.27%

04-17	Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003	MT
04-17	Cybin Selects Numinus Wellness Inc.'s Cedar Clinical Research as clinical research site for Its Phase 3 Study of CYB003	CI

Numinus Wellness Inc. is a Canada-based mental health care company. The Company helps people to heal and be well through the development and delivery of mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Company's segments include Clinical Research Operations, Canadian Clinic Network and US Clinic Network. Its Clinical Research Operations is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Its Canadian Clinic Network segment includes wellness clinics based in Canada offering clinical services, including traditional therapy and counseling, ketamine-assisted therapies, mindfulness programs, and virtual psychotherapy. The US Clinic Network segment includes wellness clinics based in the United States that offers clinical services, such as psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management.

Managers	Title	Age	Since
Payton Nyquvest CEO	Chief Executive Officer	-	62-06-25
Michael Tan PSD	President	-	18-12-31
Paul Thielking CTO	Chief Tech/Sci/R&D Officer	-	22-06-09
Evan Wood CTO	Chief Tech/Sci/R&D Officer	-	20-05-20
Bottoni Lea HRO	Human Resources Officer	-	-
Jason Lapensee PRN	Corporate Officer/Principal	-	21-05-12
Sharan Sindhu PRN	Corporate Officer/Principal	-	-
Danielle Hinan SAM	Sales & Marketing	-	-
Devon Christie PRN	Corporate Officer/Principal	-	20-06-02
Reid Robison PRN	Corporate Officer/Principal	47	22-06-09

Members of the board	Title	Age	Since
Larry Timlick BRD	Director/Board Member	67	19-01-27
Allen Morishita BRD	Director/Board Member	75	12-03-08
Payton Nyquvest CEO	Chief Executive Officer	-	62-06-25
Michael Tan PSD	President	-	18-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	316,455,100	304,120,426 ( 96.10 %)	0	96.10 %

Name	Equities	%	Valuation
Payton Nyquvest 3.111 %	8,416,148	3.111 %	639 627 $
Michael Tan 0.8991 %	2,432,508	0.8991 %	184 871 $
AdvisorShares Investments LLC 0.7809 %	2,112,666	0.7809 %	160 563 $
John Fong 0.2809 %	760,000	0.2809 %	57 760 $
Allen Morishita 0.2355 %	637,218	0.2355 %	48 429 $
Larry Timlick 0.1710 %	462,744	0.1710 %	35 169 $
Edwin Garner 0.0968 %	261,890	0.0968 %	19 904 $
NVWM LLC 0.004088 %	11,061	0.004088 %	841 $
VIMA LLC 0.000360 %	975	0.000360 %	74 $
Paula Hewitt 0.000000 %	0	0.000000 %	- $

Numinus Wellness, Inc.

33 Water Street Suite 801

V6B 1R4, Vancouver

http://numinus.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.075

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
NUMINUS WELLNESS INC.	-27.27%	17.56M
IQVIA HOLDINGS INC.	+2.21%	42.75B
LONZA GROUP AG	+47.75%	41.61B
MODERNA, INC.	+11.30%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+7.89%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.73%	18.12B
MEDPACE HOLDINGS, INC.	+29.79%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.99%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.07%	11B

Other Biotechnology & Medical Research